All News

A secondary analysis of the phase 3 TOURMALINE-MM4 trial found that ixazomib as postinduction maintenance therapy for multiple myeloma produced a progression-free survival (PFS) benefit vs a placebo across age and frailty subgroups.

People with chronic obstructive pulmonary disease (COPD) are at increased risk of long-term hearing loss, researchers find.

Perfluorohexyloctane (NOV03) was able to reduce the signs and symptoms of dry eye disease (DED) when compared with hypotonic saline control and was well tolerated.

Reducing health care disparities may require shifting from providing equal care to providing equitable care.

The weight loss surgery may help reverse peripheral neuropathy and improve the stability of cardiovascular autonomic neuropathy and retinopathy in individuals with class II/III obesity.

Animal tranquilizer xylazine has been designated an “emerging drug threat”; the White House is planning ways to implement safeguards to protect patient privacy; in 2021, sexually transmitted infections (STIs) reached a record high, the CDC finds.

Patients who had limited proficiency with English or preferred the use of another language had increased hospitalization and death rates if they delayed time to their first dose of the vaccine.

The cost savings for health plans would increase if the therapy were used after the first recurrence of Clostridioides difficile infection (CDI).

The researchers of a single-center study found that the relationships between epilepsy and autoimmune diseases may be a result of the different etiopathogenetic mechanisms that underly seizure development in each syndrome.

Health status and health-related quality of life (QOL) outcomes were compared between patients with severe cases of chronic rhinosinusitis with nasal polyps (CRSwNP) and a general patient population.

A patient with myasthenia gravis (MG) quickly deteriorated after he woke up from an endovascular procedure.

Autism is being diagnosed more often in girls; cancer medication shortages mean some patients may die before receiving treatment; new CMS policies aim to reach underserved populations.

The findings suggest recombinant ADAMTS-13 may be a useful adjunct therapy to plasma exchange among patients who have thrombotic thrombocytopenic purpura (iTTP).

There are higher risks of several major adverse cardiovascular events (MACEs) following intracerebral hemorrhage (ICH), and they include recurrent ICH, ischemic stroke, and myocardial infarction.

Coming soon: the inaugural episode of "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care,” with hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA.

Patients who were admitted to the hospital for respiratory syncytial virus (RSV) had a higher risk of a complex hospital course and had higher rates of respiratory support compared with patients admitted for influenza.

Researchers compared the effectiveness of 3 biologics for moderate to severe asthma in an observational study and found superior improvement with dupilumab.

The study was designed and conducted by undergraduate researchers.

Patients with pulmonary arterial hypertension (PAH) related to connective tissue disorders (CTDs) and patients with PAH related to another condition accrued higher costs and higher health care resource use (HRU) vs patients who had CTD without PH.

A new report from AHIP indicates that biosimilars have the potential to garner savings of $180 billion over 5 years, but there needs to be a review of the approval process for interchangeability to encourage more approvals.

A federal ruling could undermine the framework of FDA drug approvals; Florida’s warning on COVID-19 vaccines omits key data; uninsured patients with cancer struggle to find care.

Children born preterm are more likely to have respiratory symptoms at least up to middle age, according to one study.

This 4-day event drew thousands of health care leaders to Nashville, Tennessee; in this column, Ron Southwick, editor of Chief Healthcare Executive, shares his thoughts from conversations and panels in Music City.

Sashi Naidu, MD, is director of research at Carolina Blood and Cancer Care Associates, where the No One Left Alone (NOLA) initiative is working to break down cancer health disparities among its patients and prevent care fragmentation.

With the global market for biologics estimated at $382 billion just last year, and a projected global drug spend of close to $1.5 trillion by 2027, the landscape is ripe for biosimilars to help decrease the health care system’s cost burden.

Using gene enrichment analysis, a genome-wide association study (GWAS) identified a strong association with chronic obstructive pulmonary disease (COPD) and multiple ancestry groups.

The FDA has granted a fast track designation to CB-011, a CRISPR-edited allogeneic CAR T-cell therapy developed by Caribou Biosciences, for the treatment of patients with relapsed/refractory multiple myeloma.

A study of patients with acute myeloid leukemia (AML) in first remission found that the presence of certain variants indicative of measurable residual disease ahead of allogeneic hematopoietic cell transplant (HCT) was associated with relapse and worse survival.